Empowered Funds, LLC Amgen Inc Transaction History

Empowered Funds, LLC

$5.56 Billion
Q2 2024

A detailed history of Empowered Funds, LLC transactions in Amgen Inc stock. As of the latest transaction made, Empowered Funds, LLC holds 64,543 shares of AMGN stock, worth $20.4 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

64,543

Previous 32,393 99.25%

Holding current value

$20.4 Million

Previous $9.21 Million 118.98%

% of portfolio

0.36%

Previous 0.17%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$262.75 - $319.31 $8.45 Million - $10.3 Million	32,150 Added 99.25%	64,543 $20.2 Million
Q1 2024 May 06, 2024	BUY	$268.87 - $324.56 $2.5 Million - $3.02 Million	9,312 Added 40.34%	32,393 $9.21 Million
Q3 2023 Nov 01, 2023	BUY	$218.65 - $271.46 $4.08 Million - $5.07 Million	18,665 Added 422.67%	23,081 $6.2 Million
Q2 2023 Jul 27, 2023	SELL	$214.27 - $253.37 $754,658 - $892,369	-3,522 Reduced 44.37%	4,416 $980,000
Q1 2023 Apr 05, 2023	BUY	$225.79 - $275.2 $375,488 - $457,657	1,663 Added 26.5%	7,938 $1.92 Million
Q4 2022 Jan 26, 2023	BUY	$229.03 - $291.01 $390,038 - $495,590	1,703 Added 37.25%	6,275 $1.65 Million
Q3 2022 Nov 04, 2022	BUY	$224.46 - $253.15 $243,539 - $274,667	1,085 Added 31.12%	4,572 $1.03 Million
Q2 2022 Aug 01, 2022	BUY	$230.71 - $256.74 $5,306 - $5,905	23 Added 0.66%	3,487 $848,000
Q1 2022 Apr 21, 2022	BUY	$219.27 - $242.57 $94,943 - $105,032	433 Added 14.29%	3,464 $838,000
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $144,983 - $165,920	729 Added 31.67%	3,031 $682,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $215,241 - $252,181	1,014 Added 78.73%	2,302 $489,000
Q2 2021 Aug 04, 2021	BUY	$233.58 - $259.14 $300,851 - $333,772	1,288 New	1,288 $314,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empowered Funds, LLC with notifications on news.

Account

Empowered Funds, LLC Amgen Inc Transaction History